Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Publisher Information:
      2024
    • نبذة مختصرة :
      The objective of the study was to assess the cost-effectiveness of real-world spinal muscular atrophy newborn screening followed by treatment. We modeled the lifetime cost-effectiveness of the spinal muscular atrophy newborn screening followed by treatment (screening) compared to treatment without screening (no screening) from the Belgian healthcare perspective. Real-world data, including quality of life, costs, and motor development data, were collected on 12 patients identified by screening and 43 patients identified by their symptoms. "Screening" was associated with slightly higher healthcare costs (€ 6,858,061 vs. € 6,738,120) but more quality-adjusted life years (QALY) (40.95 vs. 20.34) compared to "no screening", leading to an incremental cost-effectiveness ratio of € 5,820 per QALY gained. "Screening" was dominant from a societal perspective (negative incremental costs: € -14,457; incremental QALY = 20.61), when incorporating the burden on caregivers (negative incremental costs = € -74,353; incremental QALY = 27.51), and when the treatment was chosen by the parents (negative incremental costs = € -2,596,748; incremental QALY = 20.61). Spinal muscular atrophy newborn screening coupled with early treatment is thus cost-effective compared with late treatment following clinical diagnosis and is dominant when societal perspective, caregiver burden, and treatment based on parental preference were considered.
    • الموضوع:
      Cost and quality of life; Cost-effectiveness; Medico economic analysis; Newborn screening; Real-world data; Spinal muscular atrophy; Article
    • Availability:
      Open access content. Open access content
    • Note:
      DOI: 10.1016/j.nmd.2023.11.013
      English
    • Other Numbers:
      NLMAT oai:cris.maastrichtuniversity.nl:publications/c8f51dc3-5a23-4cae-8955-4a89253799ec
      https://cris.maastrichtuniversity.nl/en/publications/c8f51dc3-5a23-4cae-8955-4a89253799ec
      1440545765
    • Contributing Source:
      UNIVERSITEIT MAASTRICHT
      From OAIster®, provided by the OCLC Cooperative.
    • الرقم المعرف:
      edsoai.on1440545765
HoldingsOnline